-The Hindu The New Drugs, Medical Devices and Cosmetics Bill is antiquated and needs to be revised The Union Health Ministry recently published a new draft Bill to replace the antiquated Drugs and Cosmetics Act, 1940. While we salute the Ministry for recognising the need for a new legislation, there is much to disagree with the new Bill. To begin with, although the Ministry has described it as being consistent with the...
More »SEARCH RESULT
Total Matching Records found : 791
In India, What Explains Distribution Margins and Drug Prices Being Linked? -Murali Neelakantan and Ashish Kulkarni
-TheWire.in A Tata Nano pays the same toll to go from Mumbai and Pune on the expressway as does a Rolls Royce. Why should pharmaceutical products be any different? On May 26, amid news reports about yet another closed-door meeting that the National Pharmaceutical Pricing Authority (NPPA) had had with unspecified stakeholders, we were reminded of an interesting press release that the Ministry of Chemicals and Fertilisers had issued in July 2021. The...
More »NGOs protest Commerce Ministry inaction on WTO COVID-19 vaccine proposal -Jacob Koshy
-The Hindu They write to Prime Minister asking him to renegotiate the draft proposal to waive intellectual property rights on vaccines and highlight the need for active engagement to improve it A group of non governmental organisations has written to Prime Minister Narendra Modi, to prod the Union Commerce Ministry into “proactively engaging” with a draft proposal at the World Trade Organisation-TRIPS in Geneva to waive intellectual property rights, mostly controlled by...
More »Is the govt. doing enough for the Jan Aushadhi scheme?
On Janaushadhi Diwas this year (i.e., March 7th, 2022), Prime Minister Shri Narendra Modi stated that the poor and the middle-class benefited from the 'Jan Aushadhi Kendras' that were set up to provide generic drugs at affordable prices. He said that the poor and the middle class saved around Rs.13,000 crore through these stores during the COVID-19 pandemic. In the wake of COVID 19 crisis, the 'Bureau of Pharma PSUs of India'...
More »Experts write to PM against WTO proposal on COVID-19 vaccine waivers -Jacob Koshy
-The Hindu “The current version of the text added new burdensome conditions that would impose additional limits on countries using non-voluntary licensing” Six experts from India, South Africa and the United States have written to Prime Minister Narendra Modi to reject the current version of a proposal at the World Trade Organisation on intellectual property waivers for COVID-19 medicines, that includes vaccines, drugs and diagnostics. In October 2020, at the WTO’s Trade Related...
More »
